Related references
Note: Only part of the references are listed.Disruption of Tacc3 function leads to in vivo tumor regression
R. Yao et al.
ONCOGENE (2012)
Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
Devendra Singh et al.
SCIENCE (2012)
A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges
Erica di Martino et al.
ADVANCES IN UROLOGY (2012)
Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo
F. R. Lamont et al.
BRITISH JOURNAL OF CANCER (2011)
A TACC3/ch-TOG/clathrin complex stabilises kinetochore fibres by inter-microtubule bridging
Daniel G. Booth et al.
EMBO JOURNAL (2011)
Src-stimulated IRTKS phosphorylation enhances cell migration
Gang Chen et al.
FEBS LETTERS (2011)
Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase
Vito Guagnano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Insulin Receptor Tyrosine Kinase Substrate Enhances Low Levels of MDM2-Mediated p53 Ubiquitination
Ke-Sheng Wang et al.
PLOS ONE (2011)
Coactivators necessary for transcriptional output of the hypoxia inducible factor, HIF, are directly recruited by ARNT PAS-B
Carrie L. Partch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Transforming acidic coiled-coil protein-3 (Tacc3) acts as a negative regulator of Notch signaling through binding to CDC10/Ankyrin repeats
Sharon Bargo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program
S. Schmidt et al.
ONCOGENE (2010)
Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes
Christopher G. Duncan et al.
ONCOTARGET (2010)
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice
Jing Qing et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner
E. di Martino et al.
ONCOGENE (2009)
The transforming acidic coiled coil 3 protein is essential for spindle-dependent chromosome alignment and mitotic survival
Leonid Schneider et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Knockdown by shRNA identifes S249C mutant FGFR3 as a potential therapeutic target in bladder cancer
D. C. Tomlinson et al.
ONCOGENE (2007)
Characterisation of IRTKS, a novel IRSp53/MIM family actin regulator with distinct filament bundling properties
Thomas H. Millard et al.
JOURNAL OF CELL SCIENCE (2007)
Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer
Chan Kwon Jung et al.
PATHOLOGY INTERNATIONAL (2006)
Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway
E. J. Chapman et al.
ONCOGENE (2006)
Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b
I Bernard-Pierrot et al.
CARCINOGENESIS (2006)
TACC3 mediates the association of MBD2 with histone acetyltransferases and relieves transcriptional repression of methylated promoters
T Angrisano et al.
NUCLEIC ACIDS RESEARCH (2006)
Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast growth factor-induced proliferation and is repressed in urothelial carcinoma cell lines
DC Tomlinson et al.
CANCER RESEARCH (2005)
Transforming acidic coiled-coil protein 3 (TACC3) controls friend of GATA-1 (FOG-1) subcellular localization and regulates the association between GATA-1 and FOG-1 during hematopoiesis
M Garriga-Canut et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Share Paper
